Cargando…
The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients
Background: Dexamethasone is used to treat cancer, relieve chemotherapy-induced nausea and vomiting, enhance cancer patients’ appetites, and treat COVID-19 patients. There is little evidence of the impact of a dexamethasone treatment plan on the severity of COVID-19 infections in cancer patients. Th...
Autores principales: | Souan, Lina, Al-Khairy, Zienab, Al-Binni, Maysaa’ Adnan, Battah, Abdelkader, Sughayer, Maher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692442/ https://www.ncbi.nlm.nih.gov/pubmed/36366306 http://dx.doi.org/10.3390/vaccines10111798 |
Ejemplares similares
-
Non-Dexamethasone Corticosteroid Therapy’s Effect on COVID-19 Prognosis in Cancer Patients: A Retrospective Study
por: Souan, Lina, et al.
Publicado: (2023) -
Comparative Assessment of the Kinetics of Cellular and Humoral Immune Responses to COVID-19 Vaccination in Cancer Patients
por: Souan, Lina, et al.
Publicado: (2023) -
An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations
por: Souan, Lina, et al.
Publicado: (2022) -
COVID-19 Antibody Seroconversion in Cancer Patients: Impact of Therapy Cessation—A Single-Center Study
por: Souan, Lina, et al.
Publicado: (2023) -
Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan
por: Souan, Lina, et al.
Publicado: (2021)